Show
Sort by
-
- Journal Article
- A1
- open access
Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+) : interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis
-
- Journal Article
- A1
- open access
Comparison of clinical features between patients with anti-synthetase syndrome and dermatomyositis : results from the MYONET registry
(2024) RHEUMATOLOGY. -
Experiences with advance care planning in amyotrophic lateral sclerosis : qualitative longitudinal study with people with amyotrophic lateral sclerosis and their family carers
-
Potential new autoimmune target in inclusion body myositis
(2024) CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. In Clinical and Experimental Rheumatology 42(2). p.505-506 -
272nd ENMC international workshop : 10 years of progress : revision of the ENMC 2013 diagnostic criteria for inclusion body myositis and clinical trial readiness. 16-18 June 2023, Hoofddorp, The Netherlands
-
- Conference Paper
- C3
- open access
Ectoine treatment stimulates protein markers of autophagy efficiency in the Duchenne muscular dystrophy mouse model mdx
(2024) JOURNAL OF NEUROLOGY AND EXPERIMENTAL NEUROSCIENCE. In Journal of Neurology and Experimental Neuroscience 10(Supplement 1). p.S8-S9 -
- Journal Article
- A1
- open access
C-terminal frameshift variant of TDP-43 with pronounced aggregation-propensity causes rimmed vacuole myopathy but not ALS/FTD
-
- Journal Article
- A1
- open access
Retrospective study shows that serum levels of chemokine CXCL10 and cytokine GDF15 support a diagnosis of sporadic inclusion body myositis and immune-mediated necrotizing myopathy
-
Anoctamin-5 related muscle disease : clinical and genetic findings in a large European cohort
-
- Journal Article
- A1
- open access
Identification of novel associations and localization of signals in idiopathic inflammatory myopathies using genome‐wide imputation